Table 1.
Baseline characteristics.
| Characteristics | Patients N = 68 n (%) |
|---|---|
| Age, median years (IQR) | 66 (59–75) |
| Male | 38 (56) |
| Race | |
| Black or African American | 1 (2) |
| Hispanic or Latino | 11 (16) |
| White | 45 (66) |
| Other | 11 (16) |
| Disease type | |
| Burkitt’s, DLBCL, PMBL | 20 (29) |
| CLL/SLL | 14 (21) |
| Hodgkin’s lymphoma (HL) | 2 (3) |
| Indolent lymphomas † | 20 (29) |
| Mantle cell lymphoma (MCL) | 3 (4) |
| T-cell lymphomas (TCLs) ‡ | 6 (10) |
| Other § | 3 (4) |
| Comorbidities | |
| Cardiovascular disease | 23 (34) |
| COPD | 5 (7) |
| Autoimmune disease †† | 5 (7) |
| Mild liver disease ‡‡ | 2 (3) |
| Diabetes | 19 (28) |
| Chronic kidney disease ¶ | 6 (10) |
| HIV/AIDS | 1 (2) |
| Smoking history | |
| Current smoker | 3 (4) |
| Former smoker | 18 (27) |
| Absolute neutrophil count at COVID-19 diagnosis | |
| Median cells × 103 (IQR) | 3.25 (2.175–4.7) |
| Less than or equal to 1000 cells/mm3 | 6 (9) |
| Absolute lymphocyte count at COVID-19 diagnosis | |
| Median cells × 103 (IQR) | 1.1 (0.7–1.625) |
| Less than or equal to 500 cells/mm3 | 15 (22) |
| Vaccine received | |
| Pfizer-BioNTech | 28 (41) |
| Moderna | 24 (35) |
| Johnson & Johnson | 1 (2) |
DLBCL—diffuse large B-cell lymphoma; PMBL—primary mediastinal B-cell lymphoma; CLL—chronic lymphocytic leukemia; SLL—small lymphocytic lymphoma; COPD—chronic obstructive pulmonary disease; HIV—human immunodeficiency virus; AIDS—acquired immunodeficiency syndrome. † Indolent lymphomas included a diagnosis of one of the following: follicular lymphomas, marginal zone lymphoma, lymphoplasmacytic lymphoma, and Waldenstrom macroglobulinemia; ‡ T-cell lymphomas included a diagnosis of one of the following: peripheral T-cell lymphomas not otherwise specified (NOS), anaplastic large cell lymphoma (ALCL), cutaneous T-cell lymphomas, angioimmunoblastic T-cell lymphoma (AITL), and acute T-cell leukemia/lymphoma (ATLL); § included Langerhans histiocytosis, hemophagocytic lymphohistiocytosis (HLH), and T-cell large granular lymphocytic leukemia (T-LGL); ¶ cardiovascular disease was defined as history of coronary artery disease, hypertension, or cerebrovascular accident; †† autoimmune disease included a diagnosis of one of the following: autoimmune disease, rheumatological disorders, and connective tissue disease; ‡‡ mild liver disease was defined as a history of chronic hepatitis or cirrhosis without portal hypertension.